Solva-Ker Gel

Manufacturer: VetriMax Veterinary Products, LLC | Salvona Technologies LLC | Shandong Xinhua Pharmaceutical Company Limited Hutian Branch
Effective date: 2025-10-02
Label type: OTC ANIMAL DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 02:45:03

Label at a glance#

ProductSolva-Ker

Active ingredientSALICYLIC ACID

Label structure9 sections

Indications and uses

For aid in the removal of excessive keratin in hyperkeratotic conditions such as: elbow calluses thickened foot pads thickened nasal planum Especially useful on geriatric animals

Dosage and administration

Apply once daily, preferably after cleansing and hydration of the affected areas. Rub gel completely into skin so that no excess medication is visible. Upon improvement, apply 2 to 3 times a week or as directed by your veterinarian.

Storage and handling

Store at room temperature. Protect from freezing.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 6.6%

Uses

INDICATIONS & USAGE SECTION

For aid in the removal of excessive keratin in hyperkeratotic conditions such as:

elbow calluses
thickened foot pads
thickened nasal planum

Especially useful on geriatric animals

Warnings

WARNINGS SECTION

For topical use only on dogs, cats, and horses. Avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water. If irritation develops, discontinue use and consult your veterinarian. For Veterinary Use Only

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion seek professional assistance or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Other information

STORAGE AND HANDLING SECTION

Store at room temperature. Protect from freezing.

Inactive ingredients

INACTIVE INGREDIENT SECTION

2-Amino-2-Methyl-1-Propanol, Betaine, Carthamus Tinctorius (Safflower) Seed Oil, Cocamidopropyl Dimethylamine, Ethylhexylglycerin, Hydroxypropyl Methylcellulose, Inositol, Olea Europaea (Olive) Fruit Extract, Phenoxyethanol, Polysorbate 80, Sodium Lactate, Taurine, Trehalose, Urea, Water, Yeast Amino Acid

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Solva-Ker Gel

1 oz / 30 ml

Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1601564	salicylic acid 6.6 % Topical Gel	PSN	8
1601564	salicylic acid 0.066 MG/MG Topical Gel	SCD	8
1601564	salicylic acid 6.6 % Topical Gel	SY	8

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d1c9d1af-bddd-448d-86f7-69052b7d5b47	Product name	1	20220627
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
ebc62596-fc97-4d03-9483-7ba095d25db7	Product name	1	20151210
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
86030-066-01	Solva-Ker	1 in 1 BOX	GEL	1		8
86030-066-30	Solva-Ker	30 mL in 1 TUBE	GEL	30		8

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	3
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	3
AMINOMETHYLPROPANOL	INACTIVE INGREDIENT	LU49E6626Q	3
BETAINE	INACTIVE INGREDIENT	3SCV180C9W	3
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	3
INOSITOL	INACTIVE INGREDIENT	4L6452S749	3
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	3
SODIUM LACTATE	INACTIVE INGREDIENT	TU7HW0W0QT	3
TAURINE	INACTIVE INGREDIENT	1EQV5MLY3D	3
TREHALOSE	INACTIVE INGREDIENT	B8WCK70T7I	3
UREA	INACTIVE INGREDIENT	8W8T17847W	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	3
YEAST, UNSPECIFIED	INACTIVE INGREDIENT	3NY3SM6B8U	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

Solva-Ker
Salicylic Acid
WATER
HYPROMELLOSE, UNSPECIFIED
AMINOMETHYLPROPANOL
UREA
YEAST, UNSPECIFIED
TREHALOSE
INOSITOL
TAURINE
BETAINE
SODIUM LACTATE
PHENOXYETHANOL
ETHYLHEXYLGLYCERIN
POLYSORBATE 80
OLIVE OIL
SAFFLOWER OIL
COCAMIDOPROPYL DIMETHYLAMINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
86030-066	86030-066-30, 86030-066-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SALICYLIC ACID	O414PZ4LPZ	ACTIB
WATER	059QF0KO0R	IACT
HYPROMELLOSE, UNSPECIFIED	3NXW29V3WO	IACT
AMINOMETHYLPROPANOL	LU49E6626Q	IACT
UREA	8W8T17847W	IACT
YEAST, UNSPECIFIED	3NY3SM6B8U	IACT
TREHALOSE	B8WCK70T7I	IACT
INOSITOL	4L6452S749	IACT
TAURINE	1EQV5MLY3D	IACT
BETAINE	3SCV180C9W	IACT
SODIUM LACTATE	TU7HW0W0QT	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
ETHYLHEXYLGLYCERIN	147D247K3P	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
OLIVE OIL	6UYK2W1W1E	IACT
SAFFLOWER OIL	65UEH262IS	IACT
COCAMIDOPROPYL DIMETHYLAMINE	L36BM7DG2T	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 49 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	GRANULE / ORAL		45 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
UREA	UREA	8W8T17847W	CREAM / VAGINAL	0.64 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	18.7 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	LOTION / TOPICAL		7 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, COATED / ORAL		58 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL, FOAM / TOPICAL		75 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
AMINOMETHYLPROPANOL	AMINOMETHYLPROPANOL	LU49E6626Q	CREAM / TOPICAL	1 %w/w		Exact identifier — unii candidate 2 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, EXTENDED RELEASE / ORAL	119.7 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	INJECTION / INTRAVENOUS		54 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
UREA	UREA	8W8T17847W	SYSTEM / TOPICAL		1260 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
UREA	UREA	8W8T17847W	TABLET, EFFERVESCENT / ORAL	60 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	221 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE / ORAL		1488 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
UREA	UREA	8W8T17847W	TABLET, COATED / ORAL	0.02 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	SOLUTION / TOPICAL	0.93 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	INSERT / VAGINAL	54.21 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	GEL / RECTAL		348 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, DELAYED RELEASE / ORAL		105 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, DELAYED RELEASE / ORAL		79 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SYSTEM / TOPICAL		54 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	JELLY / TOPICAL	NA		Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL		1127 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	SOLUTION / INTRAPERITONEAL	0.45 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	GEL / TOPICAL		4 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SUSPENSION/ DROPS / OPHTHALMIC		3 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 27 equally ranked IID candidates
AMINOMETHYLPROPANOL	AMINOMETHYLPROPANOL	LU49E6626Q	LOTION / TOPICAL	0.3 %w/w		Exact identifier — unii candidate 2 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SOLUTION / OPHTHALMIC	0.5 %w/v		Exact identifier — unii candidate 27 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	SUSPENSION / ORAL	20 mg/1ml		Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, EXTENDED RELEASE / ORAL		1472 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SUSPENSION / ORAL		305 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
UREA	UREA	8W8T17847W	INSERT / VAGINAL		50 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CREAM / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, COATED PELLETS / ORAL	3.32 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM / TOPICAL		57 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	GRANULE, FOR SUSPENSION / ORAL	1.7 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SHAMPOO / TOPICAL	3 %w/w		Exact identifier — unii candidate 27 equally ranked IID candidates
SODIUM LACTATE	SODIUM LACTATE	TU7HW0W0QT	INJECTION, SOLUTION / INFILTRATION	0.17 %v/v		Exact identifier — unii candidate 7 equally ranked IID candidates
UREA	UREA	8W8T17847W	TABLET, EXTENDED RELEASE / ORAL	0.01 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SYRUP / ORAL		250 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
UREA	UREA	8W8T17847W	DOUCHE / VAGINAL	8 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, ORALLY DISINTEGRATING / ORAL		41 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, FILM COATED / ORAL		582 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, CHEWABLE / ORAL	11.8 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SUSPENSION / OPHTHALMIC	0.5 %w/w		Exact identifier — unii candidate 27 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 49 · 964 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Saviland PRO Core-Clearing Maximum Strength Corn and Callus Pads	SALICYLIC ACID	GUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD	5af3cffb-7355-b2ce-e063-6394a90a8511	2026-09-08	Warnings	Name fallback generic name: SALICYLIC ACID
Youggle WART REMOVER	SALICYLIC ACID	Guangzhou Huixue Biotechnology Co., Ltd.	57a3744e-316c-8a3d-e063-6294a90a15d1	2026-09-08	Warnings	Name fallback generic name: SALICYLIC ACID
DVO WART REMOVER	SALICYLIC ACID	Guangzhou Huixue Biotechnology Co., Ltd.	57028c23-e012-9066-e063-6394a90a910b	2026-09-08	Warnings	Name fallback generic name: SALICYLIC ACID
Leader Maximum Strength Therapeutic Dandruff	SALICYLIC ACID	CARDINAL HEALTH 110, LLC. DBA LEADER	5afb2260-5b50-de95-e063-6394a90a5a47	2026-09-08	Warnings	Name fallback generic name: SALICYLIC ACID
Jack Black Bump Fix	SALICYLIC ACID	Jack Black, L.L.C.	e8f51678-2675-405c-8462-351ec260051a	2026-09-08	Warnings	Name fallback generic name: SALICYLIC ACID
Abib Acne foam cleanser Heartleaf foam	SALICYLIC ACID	Fourcompany Co., Ltd.	5aa353ad-0ca5-77c1-e063-6394a90a6254	2026-09-04	Warnings	Name fallback generic name: SALICYLIC ACID
Dr.Leo Acne Buster Salicylic Acid Drying	SALICYLIC ACID	Doctor Leo USA Inc	5792fa71-eb6b-3c70-e063-6394a90abde8	2026-09-03	Warnings	Name fallback generic name: SALICYLIC ACID
Blackhead Clearing Scrug	SALICYLIC ACID	Walmart Inc.	6989591a-a78b-4971-baf2-51ebfaf9c7e7	2026-09-02	Warnings, Adverse reactions	Name fallback generic name: SALICYLIC ACID
Head and Shoulders Scalp Purify Clarifying Pre-Shampoo	SALICYLIC ACID	The Procter & Gamble Manufacturing Company	5a84c545-4570-b078-e063-6394a90a8c5a	2026-09-02	Warnings	Name fallback generic name: SALICYLIC ACID
Head and Shoulders Scalp Purify Volumizing	SALICYLIC ACID	The Procter & Gamble Manufacturing Company	5a8627ec-cfd8-d0f6-e063-6394a90ab488	2026-09-02	Warnings	Name fallback generic name: SALICYLIC ACID
Head and Shoulders Scalp Soothe Cooling	SALICYLIC ACID	The Procter & Gamble Manufacturing Company	5a87ed71-87e7-a7b7-e063-6294a90ac897	2026-09-02	Warnings	Name fallback generic name: SALICYLIC ACID
DrAny WART REMOVER	SALICYLIC ACID	Hong Kong Juxin Negosyo Kag Komersyo Co., Limited	5a6b7878-060a-d528-e063-6394a90a4215	2026-09-01	Warnings	Name fallback generic name: SALICYLIC ACID
Proactivplus Pore Clearing Treatment	SALICYLIC ACID	Alchemee, LLC	334efe89-3775-5ddb-e063-6294a90ae3a8	2026-08-27	Warnings	Name fallback generic name: SALICYLIC ACID
GENTLE ACNE CLEANSER	SALICYLIC ACID	Drmtlgy, LLC	2abed972-3fae-4ef0-abb6-1883457e98be	2026-08-26	Warnings	Name fallback generic name: SALICYLIC ACID
RAVN Mens Back Acne	SALICYLIC ACID	North Forge Brands LLC	4a512df2-4ad7-495c-868a-1f4d0a886391	2026-08-26	Warnings	Name fallback generic name: SALICYLIC ACID
WART REMOVER	SALICYLIC ACID	Guangzhou Hechuang Commercial Service Co.,Ltd.	59df0688-5d06-1da4-e063-6394a90a799b	2026-08-25	Warnings	Name fallback generic name: SALICYLIC ACID
TOTCLEAR SKIN WART CORN REMOVER	SALICYLIC ACID	GOOD BRIDGE LLC	4270e1c0-5a8a-40b6-b93e-2f95e70e34eb	2026-08-25	Warnings	Name fallback generic name: SALICYLIC ACID
WART REMOVER	SALICYLIC ACID	Guangzhou Hechuang Commercial Service Co.,Ltd.	59c32b2b-5be0-74a8-e063-6394a90ab71f	2026-08-24	Warnings	Name fallback generic name: SALICYLIC ACID
WART REMOVER	SALICYLIC ACID	Yantai Dupont Daily Necessities Co., Ltd.	59c6e6f4-0393-8df1-e063-6394a90a1657	2026-08-24	Warnings	Name fallback generic name: SALICYLIC ACID
Salicylic Acid Body Wash	SALICYLIC ACID	Guangdong Danlan International Biotechnology Co., Ltd	59d671e7-7bbc-a963-e063-6394a90a776f	2026-08-24	Warnings	Name fallback generic name: SALICYLIC ACID

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.